|
September 2009
"Transplantation for multiple myeloma stage I" was addressed in a
letter to the Editor of the Oncology Times (Vol
31(17), p6).
Januari 16, 2009
A
press release following the interview on January 10,
2009
addressed a delivery method for drug combinations and bone marrow
transplant modalities.
Januari 10, 2008
Transplant Creations was
interviewed by Wallst.net,
a Financial Media Group, Inc. Company.
May 30, 2007
"Development and packaging of combination
products" at a biopharmaceutical packaging and labeling conference organized by Visiongain, London.
March 15, 2007
Transplantation for Breast Cancer: Past, Present and Future
Directions, a workshop organized and held by Transplant Creations
during the Breast Cancer conference in St. Gallen
Switzerland. A poster addressing risk
minimization in treatment of breast cancer was also presented.
Febuary 9, 2007
At the 2007 tandem BMT meetings in Denver we presented
a poster about integration of semi-high-dose autologous and
reduced intensity conditioning allogeneic transplants in therapy for
breast cancer according to our protocols and program that supports design of cost-efficient therapies (ppt,
pdf).
November 8, 2006
Transplant Creations presented at Bio Europe 2006 in Dusseldorf,
Germany
October 10, 2006
Transplant Creations was interviewed by the Wall Street Reporter; a
report was published in the March 2007 issue of the BIOMED
business journal.
October 1, 2006
"Non-myeloablative
transplants for breast cancer; rationale for treatment guidelines",
at a poster presentation at the 31st ESMO Congress in Istanbul,
Turkey.
July 9, 2006
"Non-myeloablative transplants for
early stage breast cancer", at a poster presentation at the UICC
World Cancer Conference 2006 in Washington DC, a
publication
was released.
April 8-10, 2006
At the 6th FDA Science Forum in Washington DC, we were invited to
present a poster "Product development considerations: integrated
diagnosis treatment combinations".
A listing of abstracts since
2000 can be
requested.
Up to Top Site
Map
Doelgroepen
● Academische centra & ziekenhuizen
● Biopharma & biotech industrie
● Overheden
● Gezondheidszorg industrie
● Investeerders
● Patienten groepen
● Media & pers
U wordt uitgenodigd
commentaar te leveren op de informatie op deze
website.
Voor persberichten, presentaties en interviews bezoek het engelse
gedeelte van deze pagina.
Up to Top Site
Map
| 
